 |
Sanofi to buy Genzyme for $20 billionFrench drugmaker Sanofi-Aventis SA agreed to buy Genzyme Corp with a sweetened $20.1 billion cash offer, plus payments tied to the success of the US biotech group's drugs, the companies said. The acquisition -- which comes nine months More… |
 |
Sanofi launches $18.5bn bid for GenzymeFrench drugmaker Sanofi-Aventis launched a hostile bid for Genzyme at $69 per share on Monday, taking its $18.5 billion offer direct to shareholders after Genzyme management refused to negotiate. The move comes a month after Genzyme More… |
